Search

A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukemia

Jun 12 2015 Posted in Press releases

Patients with chronic lymphocytic leukemia (CLL) that has recurred or isn’t responding to standard treatment need new therapies. A new combination of two targeted therapies is showing potential to eliminate CLL in these circumstances.

6th European CAR T-cell Meeting

Dates: February 15-17, 2024
Location: Valencia, Spain
Format: Hybrid
Chairs: Michael Hudecek & Anna Sureda

Registration is closed. Those already registratered can view on-demand content via the platform until March 17.

Curriculum-Exam Committee

Current committee members
Jose Tomás Navarro Ferrando, Spain (Chair)
Marielle Wondergem, The Netherlands (Vice-Chair)
Alicia Rovó, Switzerland (National Society representative)
Regular members
Gunnar Birgegård, Sweden
Janaki Brolin, Sweden
Carlos Fernández de Larrea, Spain
Mahesh Prahladan, United Kingdom
AimTo promote harmonization in hematology training and education in Europe and beyond…

Guidelines Committee

Current committee members
Noémi Roy, United Kingdom (Chair)
Martin Dreyling, Germany (Vice-Chair)
Steffen Koschmieder, Germany (Executive member)
Marieke Kruip, The Netherlands (Executive member)
Associate members
Tamam Bakchoul, Germany
Sabine Blum, Switzerland
Cristina Castilla Llorente, France
Lydie Da Costa, France
Carlo Dufour, Italy
Wojciech Jurczak, Poland
Simon Stanworth, United Kingdom
AimThe aim of the…

New GFI1B variants in bleeding and platelet disorders

Jun 12 2015 Posted in Press releases

Platelets restrict blood loss upon vessel damage by formation of a clot (thrombus). Recently, we reported a family with a bleeding and platelet disorder (BPD), which was caused by a defect in the gene GFI1B1.